Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2026. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 6160628015 | Interleukin 17 receptor antagonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 6160629011 | Substance with interleukin 17 receptor antagonist mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Interleukin 17 receptor antagonist | Is a | Interleukin receptor antagonist | true | Inferred relationship | Some | ||
| Interleukin 17 receptor antagonist | Has disposition (attribute) | Interleukin 17 receptor antagonist (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ixekizumab (substance) | Is a | True | Interleukin 17 receptor antagonist | Inferred relationship | Some | |
| Brodalumab (substance) | Is a | True | Interleukin 17 receptor antagonist | Inferred relationship | Some | |
| Bimekizumab (substance) | Is a | True | Interleukin 17 receptor antagonist | Inferred relationship | Some | |
| Interleukin 17 receptor antagonist-containing product | Has active ingredient | True | Interleukin 17 receptor antagonist | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR